Pediatric non-Hodgkin's lymphoma

Thomas G. Gross, Amanda M. Termuhlen

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Non-Hodgkin's lymphoma (NHL) accounts for 7% of cancer in children and adolescents in the United States, or approximately 1000 cases annually. NHL in the pediatric population differs from that observed in adult patients with respect to staging systems, histologic subtypes of disease, treatment, and outcomes. Although more than 90% of pediatric NHL is of high-grade histology, more than 80% of patients achieve long-term event-free survival with modern therapy. This review focuses on current treatments for pediatric NHL and some of the differences between NHL observed in pediatric and adult patients.

Original languageEnglish (US)
Pages (from-to)459-465
Number of pages7
JournalCurrent oncology reports
Issue number6
StatePublished - Nov 2007
Externally publishedYes

Fingerprint Dive into the research topics of 'Pediatric non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Cite this